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THE INTERFERENCE PHENOMENON IN ALLERGIC CONTACT
DERMATITIS*
WILLIAM L. EPSTEIN, M.D.t AND ALBERT M. KLIGMAN, M.D., Pu.D.
Recently we observed that the simultaneous
application of two contact allergens of unequal
sensitizing capacity did not result in the expected
incidences of sensitization; the weaker allergen
was blocked. We have called this the interference
phenomenon. This paper describes tentatively
some of its characteristics.
MATERIALS AND METHODS
The original observations were made with two
highly potent contact allergens, 2 ,4-dinitro-
chlorobenzene (DNCB) and para-nitrosodiinethyl
aniline (NDMA). The frequency of sensitization
to varying concentrations of each of these was
worked out over a period of several years in
healthy adult negro males. To sensitize, the
agents were dissolved in acetone and 0.25 ml
applied within a cup 2.9 cm in diameter under a
stream of air (open patch test). After evaporation
of the acetone the site was covered with a plastic
Band-Aid. A similar application at a new site,
using a standard concentration of 1:000, was
made one month later to determine if sensitiza-
tion had occurred. The challenge patch tests were
observed after 2, 4 and 6 days. The incidence of
sensitization for each concentration was as
follows:
Concentration
Incidence of Sensitization
DNCB NDMA
0.0005 molar.. 3/64 5% 0/24 = 0
0.0025 molar.. 6/28 16% —
0.005 0.01
molar 65/105 = 62% 62/137 = 45%
0.05 molar.... 21/23 = 91% 20/25 = 80%
0.5 molar 107/120 = 89% 42/53 79%
1.0 molar 39/45 = 87% 32/45 = 71%
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it is apparent that the sensitization-frequency
curve is roughly linear, the incidence of sensiti-
zation increasing proportionately with the con-
centration. At equal concentrations DNCB
sensitizes a higher percentage of individuals and
is adjudged the stronger sensitizer of the two.
The sensitization rates were within the expected
range when the allergens were applied simulta-
neously to separate sites, so long as the concentra-
tions were alike or nearly so. We came across the
interference phenomenon when it was observed
that the simultaneous application of unequal
concentrations of these two allergens to separate
sites gave frequency values for the weaker one
which were decidedly less than expected.
EXPEEIMEN1AL STUDY
Simultaneous Application of Unequal Concentra-
tion of DNCB and NDMA
DNCB, the stronger allergen, was applied in
a concentration 100 times that of NDMA.
0.5 molar DNCB and 0.005 molar NDMA were
applied simultaneously at different sites in 23
subjects. The resultant frequencies of sensitiza-
tion were:
Expec-ted In-
cidence
of Sen-
sitiza-
tion
Actual Incidence of
Sensitization
P
Value
DNCB (0.5 M)
NDMA (0.005 M)..
89%
45%
18/23 = 78%
3/23 = 14%
.18
<.01
* 0.05 was considered the level of significance.
Whereas, the frequency of sensitization to
DNCB fell within the expected range, there was
interference with sensitization to NDMA; the
incidence was reduced to about one third of the
expected value.
The converse experiment in which 0.5 molar
NDMA was simultaneously applied with a hun-
dred fold weaker concentration of DNCB
(0.005 M) gave the following results in 15
subjects:
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Expected mci-
dence of Sensi-
tization
Actual Incidence
of Sensitization
DNCB (0.005 M)...
NDMA (0.5 M)
62%
79%
9/15 = 60%
11/15 = 73%
Under these conditions NDMA did not inter-
fere with sensitization to DNCB. At first this
was attributed to the fact that 0.005 M DNCB
sensitizes almost as many as 0.5 M NDMA and
therefore the sensitizing capacities of these two
concentrations were not really dissimilar.
The final experiment ruled out this explana-
tion. 15 white men were exposed simultaneously
to 0.5 molar NDMA and 0.0005 molar DNCB, a
thousand fold difference. Suitable control sub-
jects were also tested.
Expected Inci-
dence of Sensitiza-
tion (Controls)
Actual Incidence
of Sensitization
DNCB (0.0005 M)..
NDMA (0.5 M)
39/13 1 = 30%
29/32 = 94%
7/15 = 40%
13/15 = 87%
NDMA stifi did not interfere with sensitiza-
tion to DNCB. Apparently, the stronger sensi-
tizer cannot be blocked by the weaker one, no
matter what the difference in concentrations
may be.
Application of Unequal Concentrations of DNCB
and NDMA at Different Times
0.005 molar NDMA was applied 5, 10, 15 and
30 days after an interfering dose of 0.5 molar
DNCB. The results were as follows:
Days after 0.5
ls& DNCB
Application
Incidence of Sensitization to NDMA
Expected Actual P Value
5
10
15
30
46%
46%
46%
46%
3/13 15%
1/10 = 10%
2/10 = 20%
5/15 = 33%
.0184
.0463
>.1
>.2
There was definite interference with NDMA
sensitization at 5 and 10 days. After 15 days the
interference effect was weaker and by 30 days
was only questionably present. It may be men-
tioned that in each case the frequency values for
DNCB were in the expected range, namely 100,
80, 90 and 93%.
Application of DNCB and Monobeneyl Ether
of Hydroquinone (MEH)
Monobenzyl ether of hydroquinone (MEH) is
a weaker contact allergen than either DNCB or
NDIVLA. A single application of a 1 M solution
in acetone sensitizes only about 6% of negro
males. By applying 0.5 M MEH in an ointment
base to skin freshly irritated by freezing (3 second
exposure to Freon 12) sensitization can be in-
creased to about 25%. This was done 5 days
after an interfering dose of 0.5 M DNCB with
the following result:
Expected Inci-
dence of Sensiti-
zation
Actual Incidence
of Sensitization
P
Value
MEH (0.5 M)..
DNCB (0.5 M).
17/73 = 23%
89%
2/25 = 8%
23/25 = 92%
0.085
Although statistical significance was border-
line due to the small sample, there appeared to
be definite evidence of interference, the ratio of
the actual to the expected frequency being about
1:3.
Application of NDMA and Less Potent Allergens
Up to this point all the successful experiments
had utilized DNCB as the blocking allergen. It
was necessary to exclude the possibility that
DNCB blocked sensitization by some pharma-
cologic property peculiar to itself. 0.5 Molar
NDMA was utilized as a blocking allergen against
formalin, a considerably weaker sensitizer. Both
allergens were applied simultaneously. A small
paper disc soaked in 2.0% aqueous solution of
formalin was applied to a site freshly irritated by
freezing and immediately occluded under an im-
permeable dressing. A control group was similarly
treated except that no NDMA was applied. The
results were as follows:
Expected mci- Actual Inci-
dence of Sensiti- deuce of Sens- V 1
zation itization a tie
2% Formalin 26/97 = 27% 2/30 = 7% 0.014
While the incidence of sensitization to NDMA
fell within expected limits, that to formalin was
evidently depressed. The experiment was re-
peated. 15 subjects were simultaneously exposed
to 0.5 molar NDMA and a full strength extract
of krameria, another weak sensitizer. The method
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of application of krameria was the same as for
formalin. At the same time control subjects were
tested with krameria alone. The results were as
follows:
Expected Incidence Actual Incidence of P
of Sensitization Sensitization Value
Krameria... 15/25 = 60% 6/15 = 40% > .3
NDMA 79% 12/15 = 80%
The results of this experiment while clearly
without statistical significance do support the
idea that NDMA can interfere with sensitization
to less potent allergens. It seems that potent
allergens other than DNCB can interfere, but if
weaker than DNCB will do so to a lesser degree.
Simultaneous Application of Two Weaker
Sensitizers
In the previous experiments only very strong
sensitizers were used as interfering allergens, and
the question arose whether or not weaker aller-
gens had this effect. The strongest sensitizers,
DNCB and NDMA, sensitize the majority of
subjects after a single application of a suitably
strong concentration. In contrast moderately
strong sensitizers, such as MEH, formalin,
1-hydrazinophthalazine (1), sensitize 2 to 25 per
cent of subjects when a strong concentration is
applied once to freshly irritated skin, whereas
weak allergens, viz, penicillin, sulfathiazole, neo-
mycin, nitrofurazone (Furacin), sensitize less
than 2 per cent under these conditions of expo-
sure. These criteria are arbitrary.
Monobenzyl ether of hydroquinone and
1-hydrazinophthalazine were the moderately
strong allergens selected to test the possibility of
interference. Of these MEH is the stronger sensi-
tizer. About 0.5 gm of a 10% concentration in
cold cream was applied to normal skin under an
occlusive dressing for 2 days. This procedure was
repeated 3 times within 12 to 15 days and the
subjects tested for sensitization in 30 days by
another application of the 10% concentration in
cold cream. The frequencies of sensitization were
determined for each compound independently.
All these subjects were healthy white males;
generally white persons are more susceptible to
contact sensitization than negroes. The results
were as follows:
Expected mci-
deuce of Sensitiza-
tion (alone)
Actual Incidence
of Sensitization
(together)
MEH
1-hydrazino-
phthalazine
6/20 30%
4/45 = 9%
15/45 33%
4/45 = 9%
No interference occurred. Apparently very
strong sensitizers are required for interference.
As a matter of fact it has been our experience
over a period of years that no interference is
present when groups of 3 or 4 moderately strong
and weak allergens are simuitaneously applied.
COMMENT
This work is preliminary and interpretations
therefore tentative. Only potent contact sensi-
tizers can exert interference. Among these there
may be a kind of heirarchy in which stronger
ones can interfere with weaker ones but not vice
versa. The interfering allergen must be used at
concentrations which give maximal rates of sensi-
tization while the allergenic strength of the
agent to be blocked must be considerably weaker.
Interference therefore is manifested only under
quite special circumstances. It is purely a labora-
tory phenomenon. In general terms interference
seems to be an instance of competitive inhibition.
The stronger allergen pre-empts the antibody
synthesizing mechanism so that the claims of the
weaker one cannot be satisfied.
Other biological examples that might help in
understanding the present phenomenon are (1)
the interference phenomenon in virology: cell
invasion by one virus may prevent invasion by a
second, competing virus (2); (2) reticuloendo-
thelial blockade: substances like India ink when
injected in large doses can temporarily block the
formation of circulating antibodies (3a); (3)
vitiation of the reticulo-endothelial system by
physical, chemical or surgical means: viz., x-rays
and poisons prevent or delay circulating antibody
production (3b); (4) immune paralysis: a massive
dose of antigen can inhibit specific antibody pro-
duction to itself (3c); (5) the "crowding out" or
"competition of antigens" effect in classic ha-
munology: occasionally, under special circum-
stances the injection of one antigen prevents the
formation of antibodies to another unrelated
one (3d, 4). Of these examples the "crowding
out" effect bears the closest resemblance to the
interference phenomenon. Here too the antigenic
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stimulus in terms of dose must be great but
potency differences are not so clear cut (5, 6).
Interestingly enough a smaller dose is satisfac-
tory when it is given as a secondary or booster
injection (7, 8). In short, the "crowding out" is
evidently due to intense antibody synthesis.
However, since the site of formation of antibodies
in allergic contact dermatitis is not known for
sure, the anRlogy can not be pressed too far.
SUMMARY AND CONCLUSION
(1) The interference phenomenon is the block-
ing of sensitization to the contactant by another
unrelated one.
(2) Only the most potent contact sensitizers
are capable of interference and only when applied
in strong concentrations. Weaker allergens can-
not block sensitization to more potent ones.
(3) The blocking effect lasts about two weeks
after application of the interfering allergen.
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DISCUSSION
DR. HERMAN N. EISEN (St. Louis, Mo.): In the
past few years a number of people have begun to
wonder about the possibility that perhaps a
single cell is incapable of giving an allergic or im-
munologic response to more than one antigenic
substance. To this end, Dr. William T. Newton
and I have done some experiments which are
quite different from those described by Dr.
Epstein and Dr. Kligman, but which have some
implications for their work.
When one injects into guinea pig footpads
dinitrophenylprotein conjugates, the animals
develop anaphylactic sensitivity specific for the
dinitrophenyl group; they do notdevelop delayed
skin sensitivity of the contact type to the dinitro-
phenyl group. Following footpad injections of
dinitrophenyl-conjugated protein, we injected
into the same footpads a simple dinitrophenyl
sensitizer in an amount which ordinarily produces
contact skin sensitization (specific for the dinitro-
phenyl group) in about half the animals. We were
quite pleased to see that under these circum-
stances no contact skin sensitization was pro-
duced, even if the simple sensitizer was injected
only one hour after the sensitizer-protein conju-
gate.
In trying to analyze the situation further, it
turned out that the interference we observed was
not immunologically specific. Since we routinely
make our sensitizing injections with sensitizer or
sensitizer-protein conjugates incorporated in
Freund's adjuvant, we repeated the above ex-
periments by making the primary injection with
Freund's adjuvant alone, omitting the dinitro-
phenyl-protein conjugate; again a second injec-
tion into the same site with the simple dinitro-
phenyl sensitizer failed to induce contact skin
sensitivity. Even when the primary injection
consisted of only incomplete Freund's adjuvant
(i.e. mineral oil, Arlacel, saline; no mycobacteria),
the second injection of simple sensitizer failed to
induce contact skin sensitivity. Consequently
the interference we observed is not specific in
any immunologic sense.
The first slide which Dr. Epstein and Dr.
Kligman showed is a beautiful dose-response
curve, except for the dip at the very high concen-
trations. Is this a real drop? It is possible I sup-
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pose that the physiological effects of putting
strongly irritant solutions on the skin will reduce
the inducing potency of the sensitizer in a manner
analogous to what Newton and I have observed
in guinea pig footpad injections. If this is the
case, the interference may not be on the immuno-
logic basis envisioned by Dr. Epstein and Dr.
Kligman.
DR. MARION B. SULzBRRGRE (New York,
N. Y.): These are fascinating studies and I con-
gratulate Bill Epstein and Kligman on pursuing
so carefully and with such interest this field of
investigation. At times one may feel that this is
such an old field, that it has been tilled so much,
that it is perhaps no longer fertile; but investiga-
tions of this type show bow many new problems
can arise and how many new approaches to old
problems are still possible here. As I have said
often, I think this is still one of the most fasci-
nating and one of the most fruitful avenues for
study in dermatology and in both applied and
theoretical immunology. I am particularly glad
to see that Dr. Epstein and his co-worker carried
out this basic work directly in man and not in
laboratory animals. Research dermatologists are
fortunate in being able to exclude a great many
variables and inexplicable, sometimes diametric
differences of species responses by carrying out
their studies directly on the living tissues of man,
on the object whose immunologic reactions arc
of the most, if not exclusive interest to us as
physicians.
I would like to ask Dr. Epstein something
about the concentrations they used. I am too
ignorant to be able to translate the molar con-
centrations he mentioned into percentages.
You will perhaps recall the experiments that Dr.
Landsteiner, Dr. Rostenberg, Jr., and I carried
out with these same two allergens about 20 years
ago. (J. Invest. Derm. 2: 25 (Feb.) 1939). To
explain them briefly,—we applied a minim of a
solution of each of these allergens, a single drop
from a tuberculin syringe similar to the manner
which the present authors have done, but si-
multaneously to each of the forearms of our
human test subjects. The solutions we used
were a 10 per cent concentration of dinitro-
chlorobenzene and a 10 per cent concentration
of para-nitrosodimethyl aniline. By observing
both the spontaneous flare-up reactions and the
reactions to subsequent challenging skin tests
with higher non-irritating dilutions, we were
able to demonstrate that these individuals be-
came sensitized in a selective manner. Some
became about eqally sensitive to both of the
chemicals; some became sensitive to neither;
some more strongly sensitive to para-nitrosodi-
methyl aniline than to dinitrochlorobenzene;
and some vice versa. In other words the in-
dividuals were selective as regards the degree of
sensitivity they developed to each compound and
also to some measure as to whether or not they
would become sensitized at all. We felt that this
selectivity itself could quite obviously have noth-
ing to do with their psychic state or their other
dietary or nutritional state, hormonal state,
etc., because the solutions werc dropped at the
same instant one on the left and one on the
right on symmetrically situated areas of the fore-
arms and the subjects had no knowledge of the
nature of the chemicals or the purposes of the
experiment. While I think it a fair assumption
that both arms of a given subject would generally
be about equal, in their "psychic state" and
immunologic lability, we even ruled out the
possibility of constant right and left differences
by switching arms, i.e. dropping one chemical
sometimes on the right arm and the same one
sometimes on the left.
In the light of our results I would like to know
what Dr. Epstein's concentrations were com-
pared to the 10 per cent acetone dilution that we
used. Of course the concentration he employed
has very direct bearing on the problem which has
been mentioned by the two previous diseussers.
Around a 10 per cent concentration in acetone,
dinitrochlorobenzene and para-nitrosodimethyl
aniline both become primary irritants. So I
would like to ask the presenters in what way they
can be certain that the interference phenomenon
which they have demonstrated here (not only
to their own satisfaction but I think also to ours),
how they can be certain that this inhibitory
interference is the result of any immunological
action at all and is not the result of having
irritated the skin with the primary irritant. The
crucial experiment would to my mind be one to
ascertain what happens when one attempts to
sensitize with a "weak allergen" after a pre-
ceding primary irritation of the skin by some-
thing which is not a sensitizer. I assume that this
has not yet been done. But I am sure Dr. Epstein
will include this sort of control in these im-
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portant studies, which I hope he is planning to
continue.
Da. WILLIAM L. EPSTEIN (in closing): I would
like to thank the discussants for their com-
ments. It would appear they have all come to the
same point. It is true that as you increase the
concentrations of the allergens you get a fall off
in sensitizing capacity of these compounds and
particularly the fall off with para-nitrosodi-
methyl aniline seems significant; it runs as low
as 50 per cent with the one molar concentration
which is very irritating. Unfortunately this has
not withstood statistical analysis because we
have not yet enough subjects; but there is
evidence in other areas that irritation will reduce
the frequency of sensitization. There is no ques-
tion about the local effect of irritants. We. Dr.
Rockwell (J.I.D. 24: 35, 1955) and many others,
have shown that severe local irritation will
depress the frequency of sensitization to allergens
applied at that site. I must remind you I tried
to point out several times that we applied these
compounds at different non-irritated sites. I
think the subtle changes that might occur at a
far distant site because of irritation from the
more potent allergen are minimal under these
circumstances and so this is not an important
criticism of the interference phenomenon. (Fol-
lowing this discussion further control subj ects
were tested with 1 molar NDMA and the results
added to the original figures. The final figure,
32/45 = 71%, occurs in the first figure of the
paper. This suggests that the original findings
(16/27 = 59%) were the result of testing too
small a sample.)
Concerning the concentrations which Dr.
Sulzberger asked about; for dinitrochlorobenzene
the one molar concentration is approximately
20 per cent. We used 0.5 molar, 10 per cent,
which is the same as the concentrations used by
Dr. Sulzberger and co-workers (J. Immun. 36:
17, 1939), but the total amount of material
applied by us was much greater than his (0.25
ml vs. 0.03 ml).
As far as Dr. Eisen's findings that the in-
jection of Freund's adjuvant decreased sensiti-
zation to secondarily injected dinitrochloro-
benzene, it is possible this was strictly an irritant
effect, but it is also possible there has been a
change in the reticuloendothelial system as a
result of the adjuvant, which prevents the R.E.S.
from taking up enough DNCB-protein for sensiti-
zation. There is fairly good evidence now that
certain substances, including P.V.P. (polyvinyl
pyrollidone) alter the reticuloendothelial system
so that it does not take up labeled colloids in the
expected manner (Weikel & Lusky, J. Pharm. &
Exptl. Therap. 118: 148, 1956).
